Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
23.86
-1.02 (-4.10%)
Sep 10, 2026, 11:04 AM EDT - Market open
Apollomics Market Cap
Apollomics has a market cap or net worth of $52.4 million as of September 10, 2026. Its market cap has increased by 324.60% in one year.
Market Cap
52.40M
Enterprise Value
49.76M
1-Year Change
324.60%
Ranking
Category
Stock Price
$23.86
ChartMarket Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $52.40M, a decrease of -59.57%. That is a compound annual growth rate of -17.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 52.40M | 30.60% |
| Dec 31, 2025 | 40.12M | 273.20% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
| Nov 26, 2021 | 129.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MindWalk Holdings | 62.96M |
| Alps Group | 62.73M |
| eXoZymes | 62.09M |
| MiNK Therapeutics | 60.11M |
| Xilio Therapeutics | 59.12M |
| ImageneBio | 59.03M |
| Annovis Bio | 57.52M |
| Seres Therapeutics | 56.81M |